bpc 157 rapid FDA Panel Recommends Compounding Unapproved

Because a pharmaceutical company cant monetize it because theres no patent on it, so I dont know when were ever going to get the real truth on this thing, because nobodys putting billions of dollars into researching it, because nobodys going to monetize it

Have absorption issues or dietary restrictions

A good candidate for self-injection is someone who is medically stable, has no bleeding disorder, is not on high-dose blood thinners without medical guidance, has completed an in-clinic training session, and has a reliable sharps container at home

For a standard KLOW-80 vial, reconstitute with 2.5 mL of BAC water for a concentration of 32 mg/mL each injection is a 0.10 mL draw (10 units on a U-100 syringe)